Image

Study of Adjuvant Nimotuzumab Combined with Nab-paclitaxel+ Gemcitabine in EGFR-positive Pancreatic Cancer

Investigational Medication with Nab-paclitaxel and Gemcitabine for EGFR-positive Pancreatic Cancer

Recruiting
18-75 years
All
Phase 2
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates the use of an investigational medication combined with chemotherapy for treating EGFR-positive pancreatic cancer. The purpose of this study is to understand how this combination works for patients who have had surgery.

The study evaluates the safety and effectiveness of the investigational medication with chemotherapy. It focuses on how well patients do without the disease coming back and other related health outcomes.

  • Who can participate: Adults aged 18 to 75 with resected pancreatic ductal adenocarcinoma and no distant metastasis can participate. Participants must have EGFR-positive status and meet specific health criteria, including adequate organ and bone marrow function.
  • Study details: Participants will receive the investigational medication combined with chemotherapy after surgery.
Print
Study details
    Pancreatic Cancer Resectable

NCT06722911

Zhejiang Provincial People's Hospital

31 July 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.